284 related articles for article (PubMed ID: 35062306)
1. High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali.
Somboro AM; Cissoko Y; Camara I; Kodio O; Tolofoudie M; Dembele E; Togo ACG; Ba DM; Sarro YDS; Baya B; Samake S; Diallo IB; Kumar A; Traore M; Kone B; Kone A; Diarra B; Dabitao DK; Wague M; Dabo G; Doumbia S; Holl JL; Murphy RL; Diallo S; Maiga AI; Maiga M; Dao S
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062306
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020-2021.
Alber D; Haidara FC; Luoma J; Adubra L; Ashorn P; Ashorn U; Badji H; Cloutman-Green E; Diallo F; Ihamuotila R; Klein N; Martell O; Onwuchekwa UU; Samaké O; Sow SO; Traore A; Wilson K; Ducker C; Fan YM
BMJ Open; 2022 Jun; 12(6):e060367. PubMed ID: 35710236
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
Front Public Health; 2022; 10():832003. PubMed ID: 35400056
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.
Goldblatt D; Johnson M; Falup-Pecurariu O; Ivaskeviciene I; Spoulou V; Tamm E; Wagner M; Zar HJ; Bleotu L; Ivaskevicius R; Papadatou I; Jõgi P; Lischka J; Franckling-Smith Z; Isarova D; Grandjean L; Zavadska D
J Hosp Infect; 2021 Apr; 110():60-66. PubMed ID: 33422589
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
Alserehi HA; Alqunaibet AM; Al-Tawfiq JA; Alharbi NK; Alshukairi AN; Alanazi KH; Bin Saleh GM; Alshehri AM; Almasoud A; Hashem AM; Alruwaily AR; Alaswad RH; Al-Mutlaq HM; Almudaiheem AA; Othman FM; Aldakeel SA; Abu Ghararah MR; Jokhdar HA; Algwizani AR; Almudarra SS; Albarrag AM
Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115273. PubMed ID: 33296851
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
[TBL] [Abstract][Full Text] [Related]
13. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
[TBL] [Abstract][Full Text] [Related]
14. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.
Recanatini C; GeurtsvanKessel CH; Pas SD; Broens EM; Maas M; van Mansfeld R; Mutsaers-van Oudheusden AJG; van Rijen M; Schippers EF; Stegeman A; Tami A; Veldkamp KE; Visser H; Voss A; Wegdam-Blans MCA; Wertheim HFL; Wever PC; Koopmans MPG; Kluytmans JAJW; Kluytmans-van den Bergh MFQ;
Antimicrob Resist Infect Control; 2023 Nov; 12(1):137. PubMed ID: 38031155
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.
Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG
Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.
Wattal C; Oberoi JK; Goel N; Datta S; Raveendran R; Rao BK; Kumar R
Indian J Med Microbiol; 2021; 39(4):528-533. PubMed ID: 34688485
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study.
Lombardi A; Mangioni D; Consonni D; Cariani L; Bono P; Cantù AP; Tiso B; Carugno M; Muscatello A; Lunghi G; Pesatori AC; Riboldi L; Ceriotti F; Bandera A; Gori A
BMJ Open; 2021 Feb; 11(2):e047216. PubMed ID: 33619203
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 seroprevalence and living conditions in Bamako (Mali): a cross-sectional multistage household survey after the first epidemic wave, 2020.
Cissoko M; Landier J; Kouriba B; Sangare AK; Katilé A; Djimde AA; Berthé I; Traore S; Thera I; Hadiata M; Sogodogo E; Coulibaly K; Guindo A; Dembele O; Sanogo S; Doumbia Z; Dara C; Altmann M; Bonnet E; Balique H; Sagaon-Teyssier L; Vidal L; Sagara I; Bendiane MK; Gaudart J
BMJ Open; 2023 Apr; 13(4):e067124. PubMed ID: 37080622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]